POULTRY DIAGNOSTICS MARKET ANALYSIS

The global poultry diagnostics market is estimated to be valued at US$ 536.7 million in 2023 and is expected to exhibit a CAGR of 11.4% during the forecast period (2023-2030).

Analysts’ Views on Global Poultry Diagnostics Market:

The global poultry diagnostics market growth can be hindered by the increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration. Adoption of organic strategies such as product launches by key market players is expected to drive the global poultry diagnostics market over the forecast period. For instance, in February 2018, BioChek, a manufacturer of veterinary diagnostics kits, announced that they had launched Avian Influenza H5-H7-H9 Multiplex, a highly sensitive and specific PCR test kit that allows the simultaneous differentiation and quantification of the hemagglutinin (HA) subtypes of Avian Influenza viruses; H5, H7, and H9 

Figure 1. Global Poultry Diagnostics Market Share (%), by Test Type, 2022

To learn more about this report, request sample copy

Global Poultry Diagnostics Market – Drivers

Increasing adoption of inorganic growth strategies such as product launches by key market players

Increasing adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global poultry diagnostics market growth over the forecast period. For instance, in April 2022, BIOMERIEUX, a biotechnology company, announced that they had launched GENE-UP QUANT Salmonella, true non-enrichment quantification diagnostic for Salmonella. The exact quantification and fast turnaround time of the new test allows poultry producers to evaluate and improve operational processes and mitigation measures, while reducing antimicrobial use, cost and waste.

Figure 2. Global Poultry Diagnostics Market Value (US$ Million), by Region, 2022

To learn more about this report, request sample copy

Global Poultry Diagnostics Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global poultry diagnostics market over the forecast period. North America holds 32.1% of the market share. Due to increasing launch of PCR (Polymerase Chain Reaction)test over the forecast period.

Global Poultry Diagnostics Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global poultry diagnostics market. For instance, in June 2020, Transasia Bio-Medicals, a diagnostic company, announced that they had received an approval from The Indian Council of Medical Research (ICMR) for ELISA antibody IgG testing kit for Covid-19 and transferred the technology to Zydus Pharmaceuticals, Inc., a pharmaceutical company, for the mass production of kits.

Global Poultry Diagnostics Market Segmentation:

The global poultry diagnostics market report is segmented into Test Type, Disease Type, End User, and Region

Based on Test Type, the market is segmented into ELISA (Enzyme-Linked Immunosorbent Assay), PCR (Polymerase Chain Reaction), and Others (Direct Agglutination Test, etc.). Out of which, the PCR (Polymerase Chain Reaction) segment is expected to dominate the poultry diagnostics market during the forecast period and this is due to the increasing launch of ELISA (Enzyme-Linked Immunosorbent Assay) test over the forecast period.

Based on Disease Type, the market is segmented into Avian Salmonellosis, Avian Influenza, Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Others (Chicken Anemia, Avian Mycoplasmosis, etc.) segment is expected to dominate the poultry diagnostics market during the forecast period and this is due to the increasing prevalence of Avian Salmonellosis over the forecast period.

Based on End User, the poultry diagnostics market is segmented into Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers. Veterinary Hospitals segment is expected to dominate the market over the forecast period and this is due to the increasing number of Veterinary Hospitals

Among all segmentation, test type segment has the highest potential due to the increasing launch of ELISA (Enzyme-Linked Immunosorbent Assay) test in North America region.

Global Poultry Diagnostics Market Cross Sectional Analysis:

In type segment, PCR test holds a dominant segment due to the increasing usage PCR test. For instance, in December 2020, a study was conducted to compare and evaluate the effect PCR test for poultry diagnostics test. The PCR test and into ELISA (Enzyme-Linked Immunosorbent Assay were operated in two different modes after PCR test had shown more positive effect for diagnostics purpose .

Global Poultry Diagnostics Market: Key Developments

• Increasing adoption of inorganic growth strategies such as product launch by key market players is expected to drive the global poultry diagnostics market over the forecast period. For instance, in October 2020, Boehringer Ingelheim International GmbH, a human, animal and poultry healthcare company, announced that they had launched VAXXITEK HVT+IBD+ILT, trivalent vaccine that protects the poultry from Infectious Laryngotracheitis, Marek's Disease and Infectious Bursal Disease (classic and variant types).

Global Poultry Diagnostics Market: Restraint

• Lack of awareness of poultry diseases is expected to hinder the global poultry diagnostics market over the forecast period. For instance, in August 2020, according to the data published in frontiers journal, emergence of poultry diseases due to improper nutrition and unsuitable environment affects the development and structure of the poultry farming.

Global Poultry Diagnostics Market - Key Players

Major players operating in the global poultry diagnostics market include Zoetis, Thermo Fisher Scientific Inc., Baltivet, Bioingentech, Devex, BioChek, QIAGEN, Bioneer Corporation, Megacor Diagnostik GmbH, Merck & Co., Inc., IdentiGEN, Abaxis, BIOMERIEUX, Transasia Bio-Medicals, Boehringer Ingelheim International GmbH, EW Group Ltd., and Hygiena, LLC.

Global Poultry Diagnostics Market – Insights

Poultry diagnostics is a diagnostic test that is administered to poultry to detect and diagnosis of poultry disease. There are various viral and bacterial diseases that cause serious damage to the productivity of the poultry industry. Avian Salmonellosis, Avian Influenza, Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Chicken Anemia, Avian Mycoplasmosis are some of the poultry diseases.  To detect the poultry diseases, poultry tests are necessary for the health management and maintenance of high productivity of poultry in farms.ELISA and PCR are the test used to detect the poultry diseases.